Clinical Study

CMV Serostatus of Donor-Recipient Pairs Influences the Risk of CMV Infection/Reactivation in HSCT Patients

Figure 2

CMV reactivation/infection with respect to donor/recipient CMV serology (a) and donor CMV IgG status independently of the serostatus of recipients (b). Acute GvHD in patients transplanted from CMV IgG negative and CMV IgG positive donors (c) (R: recipient, D: donor, “+”: CMV IgG positive, and “−”: CMV IgG negative).